Atlas Trials

SLL

14 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch SLL

RecordFirmDate
CAP-100 for Subjects With Relapsed/Refractory Chronic Lymphocytic Leukemia (NCT04704323)Catapult Therapeutics2021-09-10
Study of TG-1801 Alone or in Combination With Ublituximab in Subjects With B-Cell Lymphoma or Chronic Lymphocytic Leukemia (NCT04806035)TG Therapeutics, Inc.2021-04-28
A Time-Limited Approach to Treatment With Ibrutinib for Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma (NCT04694560)Memorial Sloan Kettering Cancer Center2020-12-22
Rituximab, Idelalisib, and Venetoclax in Relapsed/Refractory CLL/SLL (NCT03639324)Virginia Commonwealth University2020-10-02
Phase 1/2 Study of TP-0903 (an Inhibitor of AXL Kinase) in Patients With Previously Treated CLL (NCT03572634)Sumitomo Pharma America, Inc.2019-06-10
Safety, Tolerability and Efficacy of A6 in Patients With Chronic Lymphocytic Leukemia (CLL) (NCT02046928)Ångstrom Pharmaceuticals2014-02-01
Registry of the German CLL Study Group (NCT02863692)German CLL Study Group2013-08-01
Ofatumumab With High Dose Methylprednisone Followed by Ofatumumab and Alemtuzumab in 17p CLL (NCT01465334)Dana-Farber Cancer Institute2011-12-01
Bortezomib, Cladribine, and Rituximab in Treating Patients With Advanced Mantle Cell Lymphoma or Indolent Lymphoma (NCT00980395)University of Arizona2009-07-07
Ph I/II Study of Subcutaneously Administered Veltuzumab (hA20) in NHL and CLL (NCT00546793)Gilead Sciences2008-01-01

Track SLL automatically

Every clearance here is in the API, with alerts when new ones post.